USPTO serial 87833731
SAFC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 3, 2019
- Examiner
- VO, JULIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.
Need help with SAFC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Darmstadt, DE
Darmstadt, DE
Darmstadt, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William C. Wright
William C. Wright EPSTEIN DRANGEL LLP6 East 45th Street, 7th FloorNEW YORK, NY 10017United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical substances, chemical materials and chemical preparations kits for scientific purposes, consisting primarily of one or more of the following, namely, proteins, nucleic acids, cells, electrophoresis gels, reagents and also consisting of probes, buffers, coatings being stains and measuring containers for carrying out said purposes, for the expression, amplification, purification and analysis of biological samples; polymerase chain reaction (PCR) kits comprised primarily of one or more of the following, namely, proteins, nucleic acids, cells, electrophoresis gels, reagents and also consisting of probes, buffers, coatings being stains and measuring containers for carrying out said purposes, for the expression, amplification, purification and analysis of biological samples; biochemical reagents for non-medical purposes, namely, cell culture media components, supplements, and additives; biochemicals for scientific and research use, namely, monoclonal antibodies, polyclonal antibodies, purified recombinant proteins, purified natural proteins and fetal bovine serum; cell growth supplements, namely, biochemicals for affinity purification, biochemicals for western immuno blotting, biochemicals for immunocyto chemistry; blood plasma products for scientific and research use, namely, blood-typing reagents and diagnostic test kit control materials consisting primarily of monoclonal antibodies, finished blood typing reagents, purified anti-A and anti-B antibodies, buffers, reagents to monitor toxicity of drugs and immune globulins; protein and protein products in the nature of protein arrays, protein array buffers and reagents, protein microarrays for use as raw materials in the manufacturing process of biopharmaceuticals; cell culture media preparations, namely, biological tissue cultures for non-medical and non-veterinary use; inorganic salts for industrial purposes, namely, carbonate, acetate, hydroxide, chloride and hydroxidcarbonate; polyoles, namely, sorbitol, xylitol, mannitol, and lactitol, all for use in the pharmaceutical and food industry; fats and sugars used in the manufacture of pharmaceuticals; biochemical preparations derived from blood serum used as growth promoters in tissue cultures and microbiological media for use in industry and science; biological preparations for use in science, namely, blood serum fraction used in in-vitro biological research for modifying surfaces of red and white blood cells; chemicals for clinical and medical laboratory use, medical research use, and scientific research, namely, reagents for analysis, quality control, sample preparation, sample digestion and extraction; chemicals used in industry as raw materials and additives for the synthesis of organic compounds; chemical, biochemical and biological reagents and chemicals for industrial and scientific use; cells for scientific and research use; proteins for use in manufacture; proteins in raw material form, for scientific, laboratory and medical research; peptides and nucleic acids for laboratory and scientific purposes for use in gene expression technology, biological, genetic, chemical and scientific research and development; proteins for use in the manufacture of supplements for nutritional purposes in the foods and pharmaceuticals industries; Chemical substances, chemical materials and chemical preparations sold as a set, for scientific purposes, consisting primarily of one or more of the following, namely, proteins, nucleic acids, cells, gels, probes, buffers, stains and associated reagents and measuring containers for carrying out said purposes, sold as a unit with natural elements for the expression, amplification, purification and analysis of biological samples; protein and protein products in the nature of protein arrays for use as raw materials in the manufacturing process of biopharmaceuticals; peptides, nucleic acids and compositions containing cells in the nature of cell growth media for growing cells for medical or clinical use, proteins in raw material form, for scientific, laboratory and medical research | ACTIVE | — |
| 003 | Preparations for cleaning, polishing, washing and grinding; detergent soap | ACTIVE | — |
| 005 | Serological diagnostic preparations, namely, cell culture media, serum, antigens, antiserum, chemiluminescent substances; proteins supplements, protein reagents and protein based ingredients in the nature of arrays for medical, pharmaceutical and veterinary use; protein supplements for medical, pharmaceutical and veterinary use; cell culture media, namely, biological tissue cultures adapted for medical use; excipients for pharmaceutical purposes; cell growth media for growing cells for medical and clinical use, namely, preparations derived from serum used as growth promoters in tissue culture and microbiological media; diagnostic preparations for medical purposes; pharmaceutical preparations for use in industry and science, namely, medical diagnostic reagents for analysis, quality control and for sample preparation, sample digestion and extraction; proteins supplements, for pharmaceutical purposes; peptides and nucleic acids for medical and veterinary use | ACTIVE | — |
| 006 | [ Pressure-tight steel containers for the storage and extraction of laboratory chemicals, ultrapure solvents, volatile liquids and volatile air-sensitive liquids ] | SECTION 8 - CANCELLED | — |
| 007 | [ Mixers, namely, disposable industrial mixer for mixing liquids in the pharmaceutical and chemical industries; filling machines and their disposable components therefor and elbows sold as a unit for the filtration of liquids and systems composed of the same; power operated crimping tool for the sealing and cutting of tubing ] | SECTION 8 - CANCELLED | — |
| 009 | [ Disposable manufacturing apparatus and instruments, namely, disposable industrial bioreactors for growing cells in the pharmaceutical and chemical industries for laboratory use; laboratory filters, namely, tangential flow filter apparatus machines for preparation of biological samples; laboratory filters, namely, liquid filtration, purification and concentration machines for, ultrapure solvent or water based pharmaceutical preparations; Scientific, laboratory and measuring apparatus and instruments, namely, laboratory filters for liquids, housing for laboratory filters for liquids, instruments in the nature of sensors for detection of filter integrity; analysis apparatus and instruments, namely, electric sensors for detection of temperature, oxygen, pH levels, C02 and other parameters; laboratory filters, namely, liquid and gas purification filters; laboratory filter holders and housings for liquid and gas purification filters for laboratory purposes; testing apparatus, namely, liquid and gas purity testing apparatus; downloadable publications in electronic format and on cd-roms, namely, manuals and technical documentation featuring information on liquid and gas filtration; computer software for monitoring liquid and gas filtration; pressure sensors; ultra filtration filters, namely, liquid laboratory filters for laboratory purposes; kits for analysis, determination and identification of biological and chemical molecules and species comprising reaction containers in the nature of beakers, reagents, and downloadable instruction manuals; sterility testing devices, namely, electronic apparatus for testing the sterility of laboratory filtration equipment; ultrafiltration membranes, namely, scientific apparatus in the nature of cellulose mixed ester membranes and thermoplastic membranes for use in the science and research industry; fluorescence, electrochemiluminescence and bioluminescence system comprising detectors for indicating the presence of one of fluorescence, electrochemiluminescence and bioluminescence signals, an image device in the nature of a camera or microscope to show the detected signal, a laboratory filter for capturing the contamination from the liquid to be detected and reagents to label the contamination for detection and imaging by the system for detecting contamination in liquids; apparatus for performing chromatographic separations and parts thereof, namely, chromatography columns for laboratory use and control systems for liquid filtration machines for laboratory purposes; purification units, apparatus, instruments and cartridges for laboratory use, namely, laboratory apparatus in the form of liquid and gas filters; adsorptive separation devices, namely, laboratory filters having one or more chemical or charged entities for the absorption of impurities; computer software for management of biopharmaceutical purification processes; test units for determining the integrity and pore-size distribution of membrane filters, namely, testing equipment for measuring the integrity, temperature, pressure, position and form of workpieces in a machine tool; temperature sensors and electric sensors for temperature, oxygen, pH, carbon dioxide and other parameters; pH electrodes for laboratory research; laboratory membrane filters for laboratory and scientific use; laboratory filters, namely, membranes used in dialysis, reverse osmosis and ultrafiltration for laboratory and scientific use; laboratory filters, namely, liquid filtration, purification and concentration devices for laboratory use; bioreactors for cell culturing for industrial laboratory use; parts and fittings for all the aforesaid goods, namely, liquid dispense nozzles in the nature of automatic liquid dispense nozzles, laboratory storage tubes, laboratory test tubes, liquid pumps in the nature of pumps for laboratory testing purposes ] | SECTION 8 - CANCELLED | — |
| 010 | [ Filters for medical purposes, namely, filters for bacteriological and viral purposes in the nature of syringe filters ] | SECTION 8 - CANCELLED | — |
| 011 | [ Water filters and their filter components therefor; filter cartridges for water filters; filtering and purification systems comprising water filters, filter membrane, filter funnel, filtering bottle flask, centrifuge, filter holder base and support screen, syringe, filtering dispenser for the removal of contaminants from liquids and water and disposable water filtration and purification apparatus and instruments for this purpose; machines for purifying water; machine tools for purifying water; filter cartridges for water purification; apparatus for supply and return ventilation, water supply and for sanitary systems, namely, apparatus for the removal of contaminants from water and air, namely, water and air filters for domestic use; filter cartridges, apparatus, systems, devices and instruments for the purification of water, namely, water filters; purification apparatus, namely, water and air filters; purification units for industrial use, namely, water and air purification units; purification units for industrial use for removing contaminants from water and air, namely, water and air purification units; filters, namely, water and air filters for domestic use; housings and holders specially adapted for water filters; apparatus and instruments for filtration, namely, water and air filters for domestic use; tangential flow fluid filtration system comprising water filters; liquid treatment equipment in the nature of liquid treatment apparatus, namely, clarification machines for use in treatment of liquids in the nature of water and laboratory water; apparatus used in dialysis, reverse osmosis and ultrafiltration for industrial use, namely, water treatment equipment in the nature of reverse osmosis units; warm water units in the nature of water heaters; air-conditioning units; parts and fittings for all the aforesaid goods, namely, water filtration equipment in the nature of cartridge filtration units; apparatus for purification and cleaning, namely, water and air cleaning units; Anlagen, water and liquid purification units, systems comprising water and air filters, apparatus and instruments, namely, water and air filters; water and air filters for domestic use, water and air filter cartridges, water and air filter housings, all for the filtration of goods by capture and adsorption of contamination particles from fluids; pretreatment packs, namely, water filters and water treatment equipment in the nature of absorber devices in the nature of membrane based ion exchange devices being reverse osmosis units for removal of large contaminants; membrane filter cartridges for the separation of biomolecules in biopharmaceutical production; filtration and purification devices, namely, water and air filters; filters for removing contaminants from water and air for domestic use; purification elements for removing contaminants from water or liquids, namely, water filters; parts and fittings for all the aforesaid goods, namely, connectors for water purification devices, nozzles for water purification devices, tubes being parts of water purification devices and pumps, all of the foregoing connectors, nozzles, tubes, and pumps, being component parts of and sold as a unit with the water purification devices; apparatus and instruments for ion exchange, namely, purification filters for liquids and gases for use in laboratories ] | SECTION 8 - CANCELLED | — |
| 040 | Manufacturing services for others in the field of individual antibody; individual production in the nature of manufacturing for others in the field of cell cultures and biological products; manufacturing of antibodies for individuals; biomanufacturing for others, namely, manufacturing of cell cultures and biological products | ACTIVE | — |
| 041 | Training services relating to the setting up and operation of pharmaceutical and bio-technology medical product production processes; Services in the sector of training, relating to the setting up and operation of pharmaceutical and bio-technology medical product production processes | ACTIVE | — |
| 042 | Pharmaceutical and biological research services, namely, antisera research services rendered through immunogen preparation, immunization and production development, antibody characterization, antibody purification, antibody packaging design, hybridoma development and selection, custom tissue culture research services, immunoassay development and testing, immunogenicity and vivarium services; research and development and process design in the fields of human and animal pharmaceutical and biotechnology drug development and manufacture; scientific and technological services, namely, research and design in the pharmaceutical, chemical and food industry; industrial analysis and research services for the pharmaceutical, chemical and food industry; technical services in the sectors of design and validation, relating to the setting up and operation of pharmaceutical and biotechnology medical product production processes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Merck KGaA
- Other trademarks owned by Merck KGaA
- Other trademarks owned by Merck KGaA
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 006
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 011
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named SAFC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 28, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Aug 28, 2026 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Aug 28, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 29, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Dec 3, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 3, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 17, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 17, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 28, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 13, 2019 | ALIE | ASSIGNED TO LIE | — |
| Aug 2, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 10, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 10, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 10, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 10, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 17, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 17, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 17, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 3, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 3, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 3, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 9, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 9, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 9, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 9, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 9, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 9, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 31, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 21, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 17, 2018 | NWAP | NEW APPLICATION ENTERED | — |